Biostar Pharmaceuticals, Inc. Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31)
Biostar Pharmaceuticals, Inc. had Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) of $5.55 as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExercisePrice · last filed 2017-11-20
- 2017-09-30: Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) $5.55.
- 2017-06-30: Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) $5.55.
- 2017-03-31: Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) $5.55.
- 2016-12-31: Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) $5.55.
USD
| Period end | Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) |
|---|---|
| 2017-09-30 | $5.55 10-Q · filed 2017-11-20 |
| 2017-06-30 | $5.55 10-Q · filed 2017-11-15 |
| 2017-03-31 | $5.55 10-Q · filed 2017-05-19 |
| 2016-12-31 | $5.55 10-K · filed 2017-04-13 |
| 2016-09-30 | $22.61 10-Q · filed 2016-11-21 |
| 2016-06-30 | $22.61 10-Q · filed 2016-08-22 |
| 2016-03-31 | $22.61 10-Q · filed 2016-05-23 |
| 2015-09-30 | $3.23 10-Q · filed 2015-11-23 |
| 2015-06-30 | $3.23 10-Q · filed 2015-08-19 |
| 2015-03-31 | $3.23 10-Q · filed 2015-05-15 |
USD/shares
| Period end | Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) |
|---|---|
| 2017-09-30 | $5.55 10-Q · filed 2017-11-20 |
| 2017-06-30 | $5.55 10-Q · filed 2017-11-15 |
| 2017-03-31 | $5.55 10-Q · filed 2017-05-19 |
| 2016-12-31 | $5.55 10-K · filed 2017-04-13 |
| 2016-09-30 | $22.61 10-Q · filed 2016-11-21 |
| 2016-06-30 | $22.61 10-Q · filed 2016-08-22 |
| 2016-03-31 | $22.61 10-Q · filed 2016-05-23 |
| 2015-09-30 | $3.23 10-Q · filed 2015-11-23 |
| 2015-06-30 | $3.23 10-Q · filed 2015-08-19 |
| 2015-03-31 | $3.23 10-Q · filed 2015-05-15 |